title: Human umbilical vein endothelial cells increase ex vivo expansion of human CD34(+) PBPC through IL-6 secretion.
abstract: BACKGROUND
  Ex vivo expansion of hematopoietic stem cells (HSC) can help reduce cytopenia following transplantation, especially in NHL patients whose BM is deficient because of extensive chemotherapy. We have previously reported that human umbilical vein endothelial cells (HUVEC) can contribute to improved PBPC expansion when used in co-culture with CD34(+) cells.
  
  
  METHODS
  We evaluated the roles of direct HUVEC CD34(+) contact and HUVEC-produced soluble factors. We cultured CD34(+) PBPC harvested from NHL patients in four different conditions: (1) liquid culture without HUVEC; (2) co-culture in contact with HUVEC; (3) co-culture with HUVEC but without direct contact; (4) liquid culture with HUVEC-conditioned medium (CM). Thrombopoietin (Tpo), Flk2Flt3 ligand (FL) and c-kit ligand (KL) with or without rhIL-6 were added to these four culture conditions.
  
  
  CONCLUSIONS
  Our results showed that HUVEC co-culture or addition of HUVEC-CM to Tpo, FL and KL (TFK) improved CD34(+) PBPC expansion compared with liquid culture, as determined by total viable nucleated cells (TNC), colony-forming cell assay (CFC) and week-6 cobblestone area-forming cells (Wk-6 CAFC) expansions. Non-contact culture led to similar PBPC expansion as contact co-culture; moreover, HUVEC-CM improved PBPC expansion. However, when rhIL-6 was added to HUVEC-CM with TFK, no significant difference was observed. Finally, high quantities of IL-6 were detected in HUVEC-CM and addition of anti-IL-6 Ab inhibited the positive effect of HUVEC on PBPC expansion. Our results thus suggest that HUVEC may improve PBPC expansion, at least through IL-6 secretion.
authors.affiliation: Laboratoire d'Ingénierie et Thérapie Cellulaire et Tissulaire, UMR CNRS 7563 and IFR111, Faculté de Médecine, Université Henri Poincaré, Vandoeuvre-lès Nancy, France.
authors.forename: N
authors.initials: N
authors.lastname: Li
authors.forename: A
authors.initials: A
authors.lastname: Eljaafari
authors.forename: D
authors.initials: D
authors.lastname: Bensoussan
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
authors.forename: V
authors.initials: V
authors.lastname: Latger-Cannard
authors.forename: B
authors.initials: B
authors.lastname: Serrurier
authors.forename: C
authors.initials: C
authors.lastname: Boura
authors.forename: A
authors.initials: A
authors.lastname: Kennel
authors.forename: Jf
authors.initials: J
authors.lastname: Stoltz
authors.forename: P
authors.initials: P
authors.lastname: Feugier
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism*; D018929:Cell Culture Techniques; D018920:Coculture Techniques; D042783:Endothelial Cells / Q000166:cytology / Q000276:immunology*; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology / Q000276:immunology / Q000502:physiology*; D014471:Umbilical Veins / Q000166:cytology*
chemical_list: D018952:Antigens, CD34; D015850:Interleukin-6